Eli Lilly Japan Pinning New Hopes on Solanezumab; Will the Introduction of Medicoeconomic Assessments Help?

Alfonso G. Zulueta, President and General Manager, Eli Lilly Japan At a business briefing held on March 15, Alfonso G. Zulueta, president and general manager of Eli Lilly Japan, noted that “The market for Alzheimer’s disease (AD) treatments is large...read more